Chris@NNW, Author at NetworkNewsWire

MondayMar 06, 2017 8:56 am

Net Element (NASDAQ: NETE) at the Vanguard of Mobile Payment Revolution

The smartphone has become the computer we carry with us everywhere, and it has changed the way the world transacts business. Smartphones are now powerful mini-computers, personal assistants, and mobile shopping carts. From the advent of the smartphone 10 years ago, there are now an estimated 4.8 billion users globally. In just over a decade, these ubiquitous devices have created transformational business opportunities. The mobile payments industry is flourishing from this growth. By 2014, 14 percent of all mobile users in the U.S. had made a mobile payment, and a year later it was 39 percent. Some estimates suggest that…

FridayMar 03, 2017 3:27 pm

ORHub, Inc. (ORHB) Provides Cloud Based Cure for High Health Care Costs

Health care costs in the U.S. have been rising rapidly over the decades and data provided by the Kaiser Family Foundation (http://nnw.fm/f3Sc1) show the extent of that rise. In 1960, total national expenditure on health care was $27.2 billion, amounting to 5 percent of GDP. In 2015, it had climbed to $3.2 trillion, increasing by an astounding 11,785 percent to 17.8 percent of National Income (GDP). The causes are diverse: a combination of factors that include greater demand for health services and a population that is living longer. But the solutions have been less obvious. Now, ORHub, Inc. (OTC: ORHB)…

FridayMar 03, 2017 1:01 pm

MediWound (NASDAQ: MDWD) to Extend Label for Pineapple Drug to Larger Burns

When Christopher Columbus introduced the pineapple to Europe in the late fifteenth century, he undoubtedly would have had no idea that extracts from the plant could be used to treat severe thermal burns. Yet, 500 years later, a next-generation proteolytic enzyme platform for wound debridement, NexoBrid, derived from pineapples, has been developed by MediWound Ltd. (NASDAQ: MDWD). Now, positive results from a Phase II study evaluating NexoBrid will be used to support a request to the Food and Drug Administration (FDA) and the European Medicines Agency (EMA) to extend the label for NexoBrid to larger burns. The painstaking research undertaken by niche…

FridayMar 03, 2017 9:10 am

Moxian (NASDAQ: MOXC) Positioned to Profit from one of World’s Fastest Growing Markets

For companies trying to keep up with technology, social media, interactive customer acquisition, and customer loyalty programs, all while trying to grow a brick and mortar business, it can be a daunting task. To attract new customers on multiple interactive levels can require hiring entire departments of personnel to set up, organize, and execute effective strategies. It can be costly, time consuming, and require ongoing management. In Asia, more and more small- and medium-sized businesses are turning to Moxian (NASDAQ: MOXC) for turnkey solutions to all of these challenges. Moxian operates a social network platform that integrates social media and…

ThursdayMar 02, 2017 3:34 pm

India Globalization Capital, Inc. (NYSE MKT: IGC) Targets Cannabis-Based Pharmaceuticals

India Globalization Capital, Inc. (NYSE MKT: IGC) is a company in transition, now targeting pharmaceutical development in the U.S., while curtailing other businesses such as electronics trading in Hong Kong. IGC long-term plans are to establish and extend its development of phytocannabinoid-based pharmaceutical products to treat diseases such as epilepsy and cachexia. The company expects to file more patents and develop additional intellectual property in the health care industry. In the U.S., IGC develops phytocannabinoid-based treatments for epilepsy, seizures and cachexia. The goal in 2017, per CEO Ram Mukunda, is for the company to expand its cannabis-based portfolio, indicating that…

ThursdayMar 02, 2017 1:49 pm

Pressure BioSciences, Inc. (PBIO) Receives New Instrument Award from Corporate America News Magazine

On Wednesday, Pressure BioSciences, Inc. (OTCQB: PBIO) announced that it has received the award for 'Best New Instrument For Sample Preparation 2017' from Corporate America News (http://nnw.fm/D04Mx) for its Barocycler 2320Extreme. The unit is the most recent product added to PBIO’s Barocycler line. It is a smaller device designed for preparing protein samples for review. It is sold to the life science market, which is valued at roughly $6 billion, according to industry data. Pressure BioSciences, Inc. develops and sells laboratory instrumentation. It manufactures products in static and alternating pressure. The company says it has installed more than 250 of…

ThursdayMar 02, 2017 1:01 pm

Axim Biotechnologies (AXIM) Boosts Billion-Dollar Brand Portfolio with Launch of CanChew Plus™

Now that production of its next generation award-winning controlled-release cannabidiol (CBD) functional chewing gum, CanChew Plus™, has kicked off, Axim Biotechnologies (OTCQB: AXIM) has boosted its diverse billion-dollar product portfolio with another strong growth brand. With so many golden eggs in its brand basket, the company is expecting strong top line growth in the near future. Current revenue projections show AXIM could soon earn the rarified rank of unicorn. AXIM is looking ahead to a bright future with an uplisting to either the NYSE or NASDAQ. The company’s strong sales projections are built on a number of factors. The company’s…

ThursdayMar 02, 2017 9:13 am

SinglePoint, Inc. (SING) Banking on Greener Pastures

SinglePoint, Inc. (OTC: SING) has a considerable stake in the state of the legal cannabis industry. Among other things, SinglePoint is a holding company for SingleSeed, a company that provides payment services, solutions, and support for the cannabis industry. Working in tandem, SinglePoint and SingleSeed share resources and offer non-cash payment solutions, such as: Pay by Text solutions that allow customers to pay for products using their mobile phones; point of sale terminals that provide customers the convenience of using debit/credit cards right at checkout; text mobile marketing solutions; and text message marketing. SingleSeed exists to inform and educate shopkeepers…

WednesdayMar 01, 2017 2:15 pm

CytoDyn Inc.’s (CYDY) PRO 140 is One of the Most Promising Monoclonal Antibody Therapies

New forms of treatment based on monoclonal antibodies show a lot of promise for human immunodeficiency virus patients with drug resistance or limited treatment options, according to HIV/AIDS researchers at this year’s edition of the Conference on Retroviruses and Opportunistic Infections (CROI 2017), which was held last month in Seattle (http://nnw.fm/Co5Ma). Researchers focused on two monoclonal antibody therapies – PRO 140 from CytoDyn Inc. (OTCQB: CYDY) and Ibalizumab from TaiMed Biologics, both of which have shown impressive results during clinical trials as long-acting therapies for HIV patients with limited options because of HIV drug resistance. PRO 140 is currently in two…

WednesdayMar 01, 2017 1:16 pm

National Waste Management Holdings, Inc. (NWMH) is Increasing Shareholder Value with Roll-Up Strategy

With over 40 years of relevant industry experience, National Waste Management Holdings, Inc. (OTC: NWMH) is on a roll. The company continues to execute a roll-up strategy that is paying huge dividends. Since 2014, NWMH has executed five M&A transactions, which have resulted in an increased customer base, a wider menu of services and a bigger top line. Now, the company is focused on increasing shareholder value by squeezing synergies from those acquisitions. NWMH’s roll-up strategy took off on June 16, 2014, after a reverse merger with Sand/Land of Florida Enterprises, Inc. (“Sandland”), which then became a wholly-owned subsidiary of…

Financial news and publishing for public and private companies

Contact us: 512.354.7000

Author: Chris@NNW